Kyle Moore
Physician Assistant · New Albany, OHNPI 1942778386
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 143 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 33.8% of the total. Reporting peaked in 2022 at $1,000 and has fallen 97.6% since, to $24 in 2024.
Across 143 payments — averaging $14.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$688
- AstraZeneca$306
- GSK$166
- Astellas Pharma US Inc$135
- Johnson & Johnson$131
- Sanofi-aventis U.S. LLC$110
- plus $500 from 18 others
What the payments were for
- Food & beverage$2,036100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 55 | $688 |
| AstraZeneca(2 entities) | 19 | $306 |
| GSK | 15 | $166 |
| Astellas Pharma US Inc | 8 | $135 |
| Johnson & Johnson | 7 | $131 |
| Sanofi-aventis U.S. LLC | 7 | $110 |
| Bayer | 4 | $56 |
| Pfizer | 3 | $52 |
| Amgen | 3 | $49 |
| Lilly USA, LLC | 3 | $46 |
| Novo Nordisk | 3 | $44 |
| Merck | 2 | $31 |
| Biohaven Pharmaceuticals, Inc. | 2 | $29 |
| Currax Pharmaceuticals LLC | 2 | $27 |
| Nestle Healthcare Nutrition Inc. | 1 | $20 |
| Nabriva Therapeutics, PLC | 1 | $19 |
| Seqirus USA Inc | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Sunovion Pharmaceuticals Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Grifols USA, LLC | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$2,036 in reported general payments places this provider in the 85th percentile of 4,098 physician assistant providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $2,191 |
| Nabumetone | 14 | $502 |
| Atorvastatin Calcium | 23 | $211 |
| Carvedilol | 12 | $183 |
| Pantoprazole Sodium | 18 | $160 |
| ClopidogrelClopidogrel Bisulfate | 11 | $139 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 11 | $133 |
| Amlodipine Besylate | 15 | $132 |
| Tizanidine Hcl | 12 | $104 |
| Lisinopril | 15 | $88 |
| Levothyroxine Sodium | 13 | $79 |
| Losartan Potassium | 13 | $64 |
| Anastrozole | 15 | $36 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in New Albany
- Sarah LaubNew Albany$100K
- Steven WurzelbacherCincinnati$309K
- Emily AnkromDayton$192K
- Amanda MaggartWorthington$164K
- Megan SevillaMayfield Heights$132K
- Erin StrculaBelpre$106K
- Jessica RhominskiCanal Winchester$78K
- Brook GramBeloit$52K
- Alison FleigToledo$48K
- Alicia PerkinsColumbus$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.